30 participants with advanced or recurrent gynecological cancer from are enrolled for this study. Eligible participants then provide fecal specimen, blood, vaginal swab, oral mucosal swab and receive food dietary recommendation. Additional samples are collected for results analysis.
Gynecologic Cancer, Immunotherapy, Gut Microbiome
30 participants with advanced or recurrent gynecological cancer from are enrolled for this study. Eligible participants then provide fecal specimen, blood, vaginal swab, oral mucosal swab and receive food dietary recommendation. Additional samples are collected for results analysis.
Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy
-
AdventHealth Cancer Institute, Orlando, Florida, United States, 32804
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
FEMALE
No
Viome,
Momchilo Vuyisich, PhD, PRINCIPAL_INVESTIGATOR, Viome Life Sciences
2024-06